Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Anita Pramoda Biography and Net Worth

Director of Health Catalyst

Ms. Pramoda has served as CEO of Owned Outcomes, Inc. since 2014. Owned Outcomes, Inc. is a software company that provides analytical help to healthcare providers and payors as they seek financial sustainability in addition to clinical outcomes in patient care. She also serves as an Executive Advisor to Technology Crossover Ventures and on the boards at Dignity Health Foundation and Federal Reserve Bank of San Francisco (Los Angeles).

She previously served as the CFO of Epic Systems Corporation and OnTech Operations and as a board member at Allscripts. Ms. Pramoda holds a MBA from The Wharton School, University of Pennsylvania.

What is Anita Pramoda's net worth?: The estimated net worth of Anita Pramoda is at least $23,357.88 as of June 15th, 2021. Ms. Pramoda owns 4,186 shares of Health Catalyst stock worth more than $23,358 as of April 19th. This net worth estimate does not reflect any other investments that Ms. Pramoda may own. Learn More about Anita Pramoda's net worth.
How do I contact Anita Pramoda?: The corporate mailing address for Ms. Pramoda and other Health Catalyst executives is 3165 MILLROCK DRIVE SUITE 400, SALT LAKE CITY UT, 84121. Health Catalyst can also be reached via phone at (801) 708-6800 and via email at [email protected]. Learn More on Anita Pramoda's contact information.
Has Anita Pramoda been buying or selling shares of Health Catalyst?: Anita Pramoda has not been actively trading shares of Health Catalyst within the last three months. Most recently, Anita Pramoda sold 5,443 shares of the business's stock in a transaction on Tuesday, June 15th. The shares were sold at an average price of $56.53, for a transaction totalling $307,692.79. Following the completion of the sale, the director now directly owns 4,186 shares of the company's stock, valued at $236,634.58. Learn More on Anita Pramoda's trading history.
Who are Health Catalyst's active insiders?: Health Catalyst's insider roster includes Jason Alger (CAO), Daniel Burton (CEO), Bryan Hinton (CTO), Paul Horstmeier (COO), Bryan Hunt (CFO), Linda Llewelyn (Insider), James Nelli, Jr. (President), Daniel Orenstein (CEO), and Anita Pramoda (Director). Learn More on Health Catalyst's active insiders.
Are insiders buying or selling shares of Health Catalyst?: During the last year, Health Catalyst insiders bought shares 1 times. They purchased a total of 49,050 shares worth more than $499,819.50. During the last year, insiders at the sold shares 12 times. They sold a total of 19,034 shares worth more than $194,837.29. The most recent insider tranaction occured on April, 15th when insider Linda Llewelyn sold 2,005 shares worth more than $12,250.55. Insiders at Health Catalyst own 2.7% of the company. Learn More about insider trades at Health Catalyst.
Information on this page was last updated on 4/15/2024.

Anita Pramoda Insider Trading History at Health Catalyst

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/15/2021	Sell	5,443	$56.53	$307,692.79	4,186
6/1/2021	Sell	2,500	$53.56	$133,900.00	7,943
1/15/2021	Sell	34,000	$48.06	$1,634,040.00	6,690
12/17/2020	Sell	34,000	$42.04	$1,429,360.00	39,443
12/7/2020	Sell	12,000	$38.18	$458,160.00	17,443
9/10/2020	Sell	34,000	$34.18	$1,162,120.00
8/14/2020	Sell	4,000	$31.46	$125,840.00
7/15/2020	Sell	30,000	$36.20	$1,086,000.00

Anita Pramoda Buying and Selling Activity at Health Catalyst

Health Catalyst Company Overview

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

Today's Range

Now: $5.58

$5.51

$5.68

50 Day Range

MA: $7.88

$5.53

$10.26

2 Week Range

Now: $5.58

$5.51

$14.37

Volume

563,701 shs

Average Volume

613,865 shs

Market Capitalization

$326.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.29

Tiny Biotech Stock Wins $75 Billion Patent

From Behind the Markets | Ad

Find out more here >>>